| 09/14/2026 3:05 PM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/25/2026 3:12 PM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/06/2026 3:17 PM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/20/2026 3:04 PM | Finney Kevin (2053381) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/17/2026 8:50 PM | Vaxart (72444) Issuer Wheadon David E. (1789507) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/17/2026 8:50 PM | Vaxart (72444) Issuer Watson W. Mark (1612372) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/17/2026 8:50 PM | HERON ELAINE J (1235471) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/17/2026 8:50 PM | BREITMEYER JAMES B (1244823) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/17/2026 3:10 PM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/07/2026 7:00 AM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/06/2026 5:09 AM | Vaxart (72444) Filer | Form DEFA14A | |
Get the Latest News and Ratings for VXRT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vaxart and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/02/2026 4:14 PM | Vaxart (72444) Filer | Form DEFA14A | |
| 07/02/2026 8:50 AM | Houle Daniel P (2083372) Filed by Vaxart (72444) Subject | Form DFAN14A | |
| 07/02/2026 5:20 AM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/26/2026 4:23 PM | Vaxart (72444) Filer | Form DEFA14A | |
| 06/26/2026 4:29 PM | Vaxart (72444) Filer | Form DEFA14A | |
| 06/26/2026 7:54 AM | Vaxart (72444) Filer | Form DEFA14A | |
| 06/26/2026 8:00 AM | Vaxart (72444) Filer | Form DEFA14A | |
| 06/22/2026 4:26 PM | Houle Daniel P (2083372) Filed by Vaxart (72444) Subject | Form DFAN14A | |
| 06/16/2026 4:23 PM | Vaxart (72444) Filer | Form DEFA14A | |
| 06/16/2026 7:21 AM | Vaxart (72444) Filer | Form DEFA14A | |
| 06/09/2026 3:23 PM | Houle Daniel P (2083372) Filed by Vaxart (72444) Subject | Form DFAN14A | |
| 06/08/2026 4:18 PM | Vaxart (72444) Filer | Form DEFA14A | |
| 06/08/2026 3:47 PM | Houle Daniel P (2083372) Filed by Vaxart (72444) Subject | Form DFAN14A | |
| 06/08/2026 7:13 AM | Vaxart (72444) Filer | Form DEFA14A | |
| 06/04/2026 3:58 PM | Houle Daniel P (2083372) Filed by Vaxart (72444) Subject | Form DEFC14A | |
| 06/01/2026 4:10 PM | Vaxart (72444) Filer | Form DEFA14A | |
| 06/01/2026 4:00 PM | Vaxart (72444) Filer | Form ARS | |
| 06/01/2026 7:43 AM | Vaxart (72444) Filer | Form DEFA14A | |
| 06/01/2026 7:35 AM | Vaxart (72444) Filer | Form DEFA14A | |
| 06/01/2026 7:14 AM | Vaxart (72444) Subject | Form DEFC14A | |
| 05/29/2026 4:03 PM | Vaxart (72444) Filer | Form PRER14A | |
| 05/29/2026 3:48 PM | Houle Daniel P (2083372) Filed by Vaxart (72444) Subject | Form PRRN14A | |
| 05/26/2026 4:11 PM | Vaxart (72444) Issuer Watson W. Mark (1612372) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/21/2026 4:13 PM | Grasman Jeroen Nicolaas (2067766) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/21/2026 4:21 PM | Houle Daniel P (2083372) Filed by Vaxart (72444) Subject | Form PREC14A | |
| 05/20/2026 6:24 AM | Vaxart (72444) Filer | Form DEFA14A | |
| 05/20/2026 6:18 AM | Vaxart (72444) Filer | Form DEFA14A | |
| 05/19/2026 4:25 PM | Vaxart (72444) Subject | Form PREC14A | |
| 05/19/2026 4:17 PM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/19/2026 4:19 PM | Vaxart (72444) Filer | Form DEFA14A | |
Elon gets it. Do you? (Ad) Moderna's stock jumped nearly 200% in a single day after a successful Phase 3 trial for its cancer drug, and Merck added $43 billion to its market cap on the same news.
Porter & Co. says AI-driven drug discovery and automated labs are cutting development timelines by up to 80% and lifting early clinical success rates to 90%, fueling what they call biotech's Ignition Point. Stream the free Ignition Point broadcast for the full biotech breakdown. |
| 05/18/2026 11:15 PM | Vaxart (72444) Filer | Form EFFECT | |
| 05/15/2026 7:39 PM | Vaxart (72444) Filer | Form S-1/A | |
| 05/08/2026 4:30 PM | Vaxart (72444) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 05/04/2026 4:29 PM | Vaxart (72444) Filer | Form 424B5 | |
| 05/01/2026 7:54 PM | BREITMEYER JAMES B (1244823) Reporting Vaxart (72444) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/01/2026 7:55 PM | BREITMEYER JAMES B (1244823) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/23/2026 3:45 PM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/21/2026 7:30 AM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 7:30 AM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/15/2026 7:47 PM | Vaxart (72444) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 03/31/2026 3:44 PM | Cummings James F. (1886760) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 3:44 PM | Tucker Sean (1652204) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 3:51 PM | Tucker Sean (1652204) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 3:52 PM | Lo Steven (1501959) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 3:52 PM | Cummings James F. (1886760) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 3:52 PM | Berg Edward B (1912178) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 2:14 PM | Tucker Sean (1652204) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 2:15 PM | Lo Steven (1501959) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 2:15 PM | Cummings James F. (1886760) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 2:16 PM | Berg Edward B (1912178) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 8:44 PM | Lo Steven (1501959) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 6:41 PM | Berg Edward B (1912178) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 6:41 PM | Cummings James F. (1886760) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 6:42 PM | Grasman Jeroen Nicolaas (2067766) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 6:42 PM | Tucker Sean (1652204) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:53 PM | Tucker Sean (1652204) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:53 PM | Berg Edward B (1912178) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:54 PM | Cummings James F. (1886760) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 7:00 AM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/08/2025 8:43 PM | Lo Steven (1501959) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/08/2025 3:34 PM | Finney Michael J. (1650978) Reporting Vaxart (72444) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/05/2025 4:46 PM | Vaxart (72444) Issuer Watson W. Mark (1612372) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 3:20 PM | Nasdaq Stock Market LLC (1354457) Filed by Vaxart (72444) Subject | Form 25-NSE | |
| 11/21/2025 12:21 PM | HERON ELAINE J (1235471) Reporting Vaxart (72444) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 3:58 PM | Vaxart (72444) Filer | Form 424B5 | |
| 11/05/2025 3:30 PM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/10/2025 4:00 PM | Vaxart (72444) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |